Atlas Trials

Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma

Clinical trial NCT05087459 · UNKNOWN

Trial details

NCT number
NCT05087459
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Thrombocytopenia
Start date
2021-06-30
Primary completion
2022-06-01
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.